Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Dourthe

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annales De Medecine Interne|August 3, 2000
[Malignant paraganglioma of the uterus]N Isambert, P Gros, P Commegeille, et al.
Revue Des Maladies Respiratoires|January 8, 2008
[Management of non-small cell lung carcinoma following docetaxel-cisplatin. Results of an epidemiologic survey]J L Breton, G Robinet, E Dansin, et al.
La Revue De Medecine Interne|March 22, 2005
[Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature]J Desramé, C Duvic, C Bredin, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON StudyP Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trialT Powles, S A Hussain, M A Climent, et al.
Plos One|December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancerL Mineur, E François, C Plassot, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annales De Medecine Interne|August 3, 2000
[Malignant paraganglioma of the uterus]N Isambert, P Gros, P Commegeille, et al.
Revue Des Maladies Respiratoires|January 8, 2008
[Management of non-small cell lung carcinoma following docetaxel-cisplatin. Results of an epidemiologic survey]J L Breton, G Robinet, E Dansin, et al.
La Revue De Medecine Interne|March 22, 2005
[Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature]J Desramé, C Duvic, C Bredin, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON StudyP Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trialT Powles, S A Hussain, M A Climent, et al.
Plos One|December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancerL Mineur, E François, C Plassot, et al.
Pageof 2